Insights on Pharmaceuticals & Medical Products

Article

Change in the Japanese pharmaceutical market: Cradle of innovation or grave of corporate profits?
– Understanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.
Article

From product to customer experience: The new way to launch in pharma
– In increasingly crowded drug markets, a strong clinical profile is no longer enough to ensure a distinctive launch. To be successful,... pharma companies need to launch not only products but also experiences.
Article

How data is changing the pharma operations world
– Pharma companies have a great opportunity to turn a buzzword into exponential impact.
Article

Real-world evidence: Driving a new drug-development paradigm in oncology
– The potential for real-world evidence is expanding, particularly in oncology drug development. To compete, some companies are... investing in robust real-world data and analytic capabilities.
Article

Five things to know about biosimilars right now
– In the biosimilars market, companies face declining prices and rising competition. What themes will shape the industry in coming... months, and how can players set themselves apart?

Special Collections

Biopharma Frontiers:
What the future holds for the industry
Industry leaders and key stakeholders offer perspectives to inspire discussion and constructive debate.

The pharma launchpad
Ideas for pharma and biotech looking to invest for launch success.

Spotlight on Japan
As the world’s second-largest pharma and medtech market, Japan has historically been an innovation center for the industry.... But amid an evolving healthcare landscape, this collection of articles and interviews looks at what opportunities and challenges executives at life-sciences companies need to address.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

Learn more

More insights

Report

Data driven decisions in cancer care
– EMR- and biomarker-based diagnostics are now ubiquitous in oncology. But several factors hinder greater use of automation and... analytics-driven decisions. This paper examines these limitations and suggests solutions.
Article - McKinsey Quarterly

Shaking up the value chain
– Data and digitization are creating a growing array of value-creation choices in industries as diverse as pharmaceuticals, mining,... and energy.
Interview

Leading change in the Japanese pharma market: Innovating for the future in an uncertain present
– Jacques Nathan, president of Sanofi Japan, discusses what’s ahead for his changing sector.
Article

How data is changing the pharma operations world
– Pharma companies have a great opportunity to turn a buzzword into exponential impact.
Interview

Bringing an animal health business into the fold
– Two senior Boehringer Ingelheim executives, Joachim Hasenmaier and Felix Gutsche, discuss the global pharmaceutical company’s... deal with Sanofi to acquire its animal health business.
Article

How new biomolecular platforms and digital technologies are changing R&D
– By going digital, biotech pioneers with promising biomolecular platforms are improving drug discovery and development—and... changing the pharmaceutical industry.
Article

Designing a healthy future for medical devices
– Design is increasingly a business imperative, but medtech companies have been slow to embrace it. What benefits might a focus... on medical-device design bring, and how can companies get started?
Interview

Collaborating to address our global public health challenges
– Jaak Peeters, head of global public health at Johnson & Johnson, discusses the role pharma can play in addressing big challenges,... such as fighting diseases like HIV and tuberculosis.
Interview

Operations as a competitive advantage in biotechnology
– Esteban Santos, executive vice president for operations at Amgen, explains how the company is using operations to support innovation.
Article

Expanding horizons for risk management in pharma
– With risks mounting, drugmakers can take a page from other highly regulated, capital-intensive businesses.
Article

Asia on the move: Five trends shaping the Asia biopharmaceutical market
– Enthusiasm for the biopharmaceutical sector in Asia has been flat, due in part to China’s market-access blockade, Japan’s... spending controls, and deceleration in India and Southeast Asia. Recent changes have reignited interest in the region, with important implications for pharma executives.
Sorry, we couldn't find any results. Try removing some filters.
View more

Related practices

Connect with our Pharmaceuticals & Medical Products Practice

Contact